⌕
United Therapeutics · UTHR · Nasdaq
Tenet 72 · Solid
Compare
$584.10−0.64%At closeTenet 72 · Solid
$584.10−3.78 (−0.64%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

United Therapeutics (UTHR) Institutional Ownership

13F filers reported holding 23.2% of United Therapeutics (UTHR) shares as of Sep 30, 2026, across 478 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
23.2%
Sep 30, 2026
13F filers
478
quarter ended Sep 30, 2026
13F value
$5.3B
9.9M shares
Quarter's fund flow
Mild distribution
49 new · 42 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds trimmed or exited than added or entered, mild distribution (49 new · 154 increased · 185 reduced · 42 closed · 48 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 478 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Nov 6, 2026ROTHBLATT MARTINE AChairperson & CEOAcquired · Option exercise9,500$117.76↗
Nov 6, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale109$560.79↗
Nov 6, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale2,005$561.80↗
Nov 6, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale1,136$562.87↗
Nov 6, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale870$563.85↗
Nov 6, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale1,776$564.99↗
Nov 6, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale1,742$565.85↗
Nov 6, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale1,021$566.83↗
Nov 6, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale761$567.64↗
Nov 6, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale80$568.68↗
Nov 6, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Option exercise9,500Stock Option—↗
Nov 5, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale200$593.14↗
Nov 5, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale280$594.51↗
Nov 5, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale120$595.43↗
Nov 5, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale306$596.71↗
Nov 5, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale237$597.74↗
Nov 5, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale167$598.74↗
Nov 5, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale10$599.80↗
Nov 5, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale560$601.11↗
Nov 5, 2026ROTHBLATT MARTINE AChairperson & CEODisposed · Open-market sale80$602.49↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of United Therapeutics do institutions hold?

13F filers reported holding 23.2% of United Therapeutics' shares as of Sep 30, 2026, across 478 filers.

How many 13F filers hold United Therapeutics?

United Therapeutics was held by 478 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.